Description
VYVGART (efgartigimod alfa-fcab) is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients
who are anti-acetylcholine receptor (AChR) antibody positive.
Additional information
| Brand | VYVGART |
|---|---|
| Generic name | Efgartigimod alfa-fcab Injection |
| Form | Parenteral |
| Strength | 400mg/20ml |
| Manufacturer | Vetter pharma |
| Documents | Either PO or prescription |
| Storage | 2-8°C temperature |
Reviews
There are no reviews yet.